Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
Beta-adrenergic blockers are a valuable class of cardiovascular drugs and are widely used in the treatment of arterial hypertension (AH), coronary heart disease, chronic heart failure (CHF), cardiac arrhythmias, significantly improving the prognosis of patients. However, the clinical efficacy of bet...
Saved in:
| Main Authors: | V. N. Larina, M. V. Leonova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2588 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
by: Maryam Izadi, et al.
Published: (2024-10-01) -
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01) -
Βeta-adrenergic receptor reactivity of erythrocyte membranes in patients with left or right atrial dilatation against the background of atrial fibrillation
by: E. F. Muslimova, et al.
Published: (2023-10-01) -
ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01) -
BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)